Drugs / abnobaVISCUM® Quercus
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01401075 | Mar 2006 → Apr 2008 | gastric cancer | Abnoba GmbH | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | abnobaVISCUM Quercus | “Evaluation of safety and efficacy of a standardized mistletoe extract (abnobaVISCUM® Quercus, aVQ) in patients with gastric cancer receiving oral chemotherapy.” NCT01401075 ↗ |
| Known as | aVQ | “Evaluation of safety and efficacy of a standardized mistletoe extract (abnobaVISCUM® Quercus, aVQ) in patients with gastric cancer receiving oral chemotherapy.” NCT01401075 ↗ |
| Route | Subcutaneous | “aVQ was injected subcutaneously three times per week from postoperative day 7 to week 24 in increasing doses.” PMID 23033982 ↗ Oct 2012 |